Nov 15, 2023
GLP-1 drugs are gaining popularity as an innovative solution to
weight loss. With almost 43% of the US population being obese, this
presents a strategic opportunity for the healthcare industry. Only
20% of Semaglutide users experience side effects, and the
significant advertising spending by Rx manufacturers is driving
demand for this new class of weight loss drugs.
In episode 48 of Kantar’s Retail Sound Bites, hosts Barry Thomas,
senior retail thought leader, and Rachel Dalton, head of retail
insights, discuss GLP-1 medications and their influence on the
retail landscape with nurse practitioners Leslie Thomas and Cathy
Watkins lead the Signature Image Medical Spa in Atlanta,
GA.
Have a topic you’d like us to cover? Contact us at Kantar’s
Retail Sound Bites Podcast.
Barry’s contact information:
barry.thomas@kantar.com
Barry’s LinkedIn
Rachel’s contact information:
rachel.dalton@kantar.com
Rachel’s LinkedIn
https://www.signatureimageatlanta.com/
OpenAI’s new
GPTs now let uses create custom versions of
ChatGPT www.openai.com
Viral streamer partners with
Kellogg’s veteran to launch BFY snack
company https://www.usatoday.com/story/money/food/2023/11/13/twitch-streamer-pokimane-launches-myna-snacks/71136108007/
Pizza Hut’s ‘Your Mood, Your
Pizza’ campaign uses AI to suggest
items www.dominos.com
https://www.wsj.com/business/ozempic-impact-snack-food-companies-9eec87e5?mod=retail_more_article_pos45
https://www.cnn.com/2023/11/13/business/self-checkout-stores-shopping/index.html
https://www.cnbc.com/2023/11/10/amazon-top-fresh-exec-says-store-reopenings-part-of-grocery-revamp.html
